Save the Dates
November 12 – 14, 2024 • Joseph B. Martin Conference Center, Boston, MA
2022 Organizing Committee
The Annual Personalized Medicine Conference is organized by a cross-industry, cross-disciplinary panel, made up of providers, payers, educators, researchers and other stakeholders — all of whom believe that collaborative dialogue is essential to the advancement of personalized medicine.
![](https://www.personalizedmedicineconference.org/wp-content/uploads/2018/04/e_abrahams.png)
Chair
EDWARD ABRAHAMS, PH.D.
President, Personalized Medicine Coalition
![](https://www.personalizedmedicineconference.org/wp-content/uploads/2018/04/b_addario.png)
Bonnie J. Addario
Co-Founder, Board Chair, GO2 Foundation for Lung Cancer
![](https://www.personalizedmedicineconference.org/wp-content/uploads/2018/04/a_andreu-2.png)
Antonio L. Andreu, M.D., Ph.D.
Scientific Director, EATRIS (European Infrastructure for Translational Medicine)
![](https://www.personalizedmedicineconference.org/wp-content/uploads/2020/02/m_bazile.png)
Mandy Bazile
Senior Director, Public Policy and Reimbursement, Genentech
![](https://www.personalizedmedicineconference.org/wp-content/uploads/2018/04/m_bordoni.png)
Mary Bordoni
Director, Strategic Alliance Development, Federal Government Affairs, Bristol Myers Squibb
![](https://www.personalizedmedicineconference.org/wp-content/uploads/2018/04/w_dalton.png)
William Dalton, Ph.D., M.D.
Founder, Senior Advisor, M2Gen
![](https://www.personalizedmedicineconference.org/wp-content/uploads/2018/06/s_eck.png)
Stephen L. Eck, M.D., Ph.D.
Senior Vice President, Clinical Development, Chief Medical Officer, MacroGenics
![](https://www.personalizedmedicineconference.org/wp-content/uploads/2020/01/o_ekinci.png)
Okan Ekinci, M.D.
Senior Vice President, Global Head of Marketing and Innovation, Roche Diagnostics Information Solutions
![](https://www.personalizedmedicineconference.org/wp-content/uploads/2020/01/l_frank.png)
Lori Frank, Ph.D.
Senior Vice President, Research, Policy, and Programs, The New York Academy of Medicine; Medical, Scientific, and Memory Screening Advisory Board Member, Alzheimer’s Foundation of America
![](https://www.personalizedmedicineconference.org/wp-content/uploads/2018/04/r_hamermesh.png)
Richard Hamermesh, D.B.A.
Co-Faculty Chair, Harvard Business School Kraft Precision Medicine Accelerator
![](https://www.personalizedmedicineconference.org/wp-content/uploads/2019/03/k_joshi.png)
Kris Joshi, Ph.D.
Executive Vice President, President, Network Solutions, Change Healthcare
![](https://www.personalizedmedicineconference.org/wp-content/uploads/2020/01/r_knight.png)
Richard Knight
President, American Association of Kidney Patients
![](https://www.personalizedmedicineconference.org/wp-content/uploads/2020/01/a_martin.png)
Anne-Marie Martin, Ph.D.
Senior Vice President, Global Head of Experimental Medicine, GlaxoSmithKline
![](https://www.personalizedmedicineconference.org/wp-content/uploads/2018/04/s_mcclure.png)
Susan McClure
Founder, CEO, Genome Creative
![](https://www.personalizedmedicineconference.org/wp-content/uploads/2019/03/h_mcleod.png)
Howard McLeod, Pharm.D.
Executive Clinical Director, Precision Health, Intermountain Healthcare
![](https://www.personalizedmedicineconference.org/wp-content/uploads/2018/04/t_miller.png)
Tom Miller
Founder, Managing Partner, GreyBird Ventures
![](https://www.personalizedmedicineconference.org/wp-content/uploads/2018/03/fpo-speaker-2.png)
Lincoln Nadauld, M.D., Ph.D.
Vice President, Chief of Precision Health and Academics, Intermountain Healthcare
![](https://www.personalizedmedicineconference.org/wp-content/uploads/2018/04/m_pellini.png)
Michael J. Pellini, M.D.
Managing Partner, Section 32
![](https://www.personalizedmedicineconference.org/wp-content/uploads/2020/10/a_qadan.png)
Ammar Qadan
Vice President, Global Head of Market Access, Illumina
![](https://www.personalizedmedicineconference.org/wp-content/uploads/2020/01/h_sakul.png)
Hakan Sakul, Ph.D.
Vice President, Head of Diagnostics, Pfizer
![](https://www.personalizedmedicineconference.org/wp-content/uploads/2018/04/m_sherman10.png)
Michael Sherman, M.D.
Executive Vice President, Chief Medical Officer, Point32Health
![](https://www.personalizedmedicineconference.org/wp-content/uploads/2020/01/l_silvis.png)
Lauren Silvis
Senior Vice President, External Affairs, Tempus
![](https://www.personalizedmedicineconference.org/wp-content/uploads/2018/04/r_snyderman-1.png)
Ralph Snyderman, M.D.
James B. Duke Distinguished Professor of Medicine, Duke University
![](https://www.personalizedmedicineconference.org/wp-content/uploads/2018/04/m_stevenson.png)
Mark P. Stevenson
Board Member, Personalized Medicine Coalition
![](https://www.personalizedmedicineconference.org/wp-content/uploads/2018/06/b_toner.png)
Bernadette Toner
CEO, GenomeWeb
![](https://www.personalizedmedicineconference.org/wp-content/uploads/2020/01/a_tsimberidou.png)
Apostolia M. Tsimberidou, M.D., Ph.D.
Professor, The University of Texas MD Anderson Cancer Center
![](https://www.personalizedmedicineconference.org/wp-content/uploads/2018/04/a_vadas.png)
Alex Vadas, Ph.D.
Managing Director, Partner, LEK Consulting
![](https://www.personalizedmedicineconference.org/wp-content/uploads/2019/03/w_verbiest.png)
Werner Verbiest
Strategic Partnerships and Alliances Leader, Janssen Pharmaceutical Companies of Johnson & Johnson
![](https://www.personalizedmedicineconference.org/wp-content/uploads/2018/06/j_wohlgemuth-1.png)
Jay G. Wohlgemuth, M.D.
Chief Medical Officer, Senior Vice President, Research and Development, Medical, Population Health, Quest Diagnostics